HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,177,872 | +17.2% | 1,732,405 | +10.6% | 0.01% | +18.2% |
| Q2 2023 | $56,476,819 | -8.0% | 1,565,756 | -2.6% | 0.01% | -15.4% |
| Q1 2023 | $61,382,710 | -45.9% | 1,607,298 | -19.4% | 0.01% | -48.0% |
| Q4 2022 | $113,413,421 | +44.6% | 1,993,206 | +0.5% | 0.02% | +38.9% |
| Q3 2022 | $78,444,000 | +7.3% | 1,983,941 | +19.4% | 0.02% | +5.9% |
| Q2 2022 | $73,094,000 | -6.6% | 1,661,239 | -15.4% | 0.02% | +6.2% |
| Q1 2022 | $78,272,000 | -29.6% | 1,962,697 | -29.0% | 0.02% | -27.3% |
| Q4 2021 | $111,191,000 | +20.5% | 2,765,247 | +21.9% | 0.02% | +10.0% |
| Q3 2021 | $92,244,000 | +4.3% | 2,267,542 | +16.5% | 0.02% | 0.0% |
| Q2 2021 | $88,408,000 | -21.0% | 1,946,885 | -27.5% | 0.02% | -31.0% |
| Q1 2021 | $111,926,000 | -0.6% | 2,684,709 | +1.8% | 0.03% | 0.0% |
| Q4 2020 | $112,619,000 | +68.4% | 2,636,813 | +3.6% | 0.03% | +52.6% |
| Q3 2020 | $66,895,000 | +67.9% | 2,545,481 | +71.3% | 0.02% | +58.3% |
| Q2 2020 | $39,837,000 | +123.8% | 1,485,915 | +50.2% | 0.01% | +100.0% |
| Q1 2020 | $17,800,000 | +11.0% | 989,369 | +9.4% | 0.01% | +50.0% |
| Q4 2019 | $16,031,000 | -35.5% | 904,214 | -43.6% | 0.00% | -42.9% |
| Q3 2019 | $24,873,000 | +3.2% | 1,603,701 | +14.4% | 0.01% | 0.0% |
| Q2 2019 | $24,094,000 | -1.1% | 1,402,444 | -7.3% | 0.01% | 0.0% |
| Q1 2019 | $24,351,000 | -12.7% | 1,512,483 | -20.6% | 0.01% | -22.2% |
| Q4 2018 | $27,882,000 | -7.7% | 1,905,808 | +14.6% | 0.01% | +12.5% |
| Q3 2018 | $30,205,000 | +21.2% | 1,662,376 | +12.5% | 0.01% | +14.3% |
| Q2 2018 | $24,929,000 | -4.8% | 1,477,740 | +10.5% | 0.01% | 0.0% |
| Q1 2018 | $26,188,000 | +47.9% | 1,336,836 | +52.9% | 0.01% | +75.0% |
| Q4 2017 | $17,710,000 | +128.7% | 874,133 | +96.1% | 0.00% | +100.0% |
| Q3 2017 | $7,743,000 | +48.1% | 445,769 | +9.3% | 0.00% | +100.0% |
| Q2 2017 | $5,229,000 | +92.1% | 407,884 | +94.2% | 0.00% | 0.0% |
| Q1 2017 | $2,722,000 | +27.6% | 210,027 | -2.7% | 0.00% | 0.0% |
| Q4 2016 | $2,133,000 | +23.9% | 215,880 | +51.5% | 0.00% | 0.0% |
| Q3 2016 | $1,722,000 | -43.1% | 142,542 | -59.3% | 0.00% | 0.0% |
| Q2 2016 | $3,026,000 | -26.1% | 350,596 | -18.9% | 0.00% | 0.0% |
| Q1 2016 | $4,096,000 | -44.4% | 432,496 | +1.7% | 0.00% | -50.0% |
| Q4 2015 | $7,365,000 | +54.3% | 425,079 | +19.6% | 0.00% | 0.0% |
| Q3 2015 | $4,773,000 | +33.7% | 355,373 | +124.7% | 0.00% | +100.0% |
| Q2 2015 | $3,571,000 | +8.0% | 158,151 | -31.7% | 0.00% | 0.0% |
| Q1 2015 | $3,305,000 | -0.1% | 231,475 | -32.5% | 0.00% | 0.0% |
| Q4 2014 | $3,309,000 | +115.3% | 342,907 | +103.0% | 0.00% | – |
| Q3 2014 | $1,537,000 | -18.9% | 168,904 | -12.0% | 0.00% | -100.0% |
| Q2 2014 | $1,895,000 | -61.4% | 191,831 | -50.4% | 0.00% | 0.0% |
| Q1 2014 | $4,914,000 | +116.8% | 386,899 | +155.9% | 0.00% | 0.0% |
| Q4 2013 | $2,267,000 | +18.6% | 151,208 | -12.7% | 0.00% | 0.0% |
| Q3 2013 | $1,912,000 | +41.8% | 173,234 | +2.2% | 0.00% | 0.0% |
| Q2 2013 | $1,348,000 | +40.3% | 169,536 | +18.4% | 0.00% | – |
| Q4 2012 | $961,000 | -58.1% | 143,190 | -53.0% | 0.00% | – |
| Q3 2012 | $2,295,000 | -61.3% | 304,471 | -54.5% | 0.00% | -100.0% |
| Q2 2012 | $5,929,000 | -26.1% | 669,260 | +6.5% | 0.00% | -25.0% |
| Q1 2012 | $8,018,000 | – | 628,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |